Trimethoprim In Vitro Antibacterial Activity is Not Increased by Adding Sulfamethoxazole for Pediatric Escherichia coli Urinary Tract Infection

Journal of Urology

Volumn 184, Issue 1, 2010, Pages 305-310

  Nguyen, Hiep T ^a   Hurwitz, Richard S ^a   DeFoor, W Robert ^a   Minevich, Eugene ^a   McAdam, Alexander J ^a   Mortensen, Joel E ^a   Novak Weekley, Susan M ^a   Minnillo, Brian J ^a   Elder, Jack S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

drug hypersensitivity; Escherichia coli infections; trimethoprim sulfamethoxazole combination; urinary tract; urinary tract infections

Indexed keywords

AMPICILLIN; COTRIMOXAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

AMERICAN FOULBROOD; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CHILDHOOD DISEASE; CITROBACTER; DISK DIFFUSION; ENTEROBACTER; ENTEROCOCCUS FAECALIS; HUMAN; IN VITRO STUDY; KLEBSIELLA OXYTOCA; MAJOR CLINICAL STUDY; MORGANELLA MORGANII; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

AMPICILLIN; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS, URINARY; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; SULFAMETHOXAZOLE; TREATMENT OUTCOME; TRIMETHOPRIM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UNITED STATES; URINARY TRACT INFECTIONS;

EID: 77953230201     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.084     Document Type: Article

References (30)

1. Nickel J.C. Management of urinary tract infections: historical perspective and current strategies. Part 2: modern management. J Urol 173 (2005) 27
2. Brumfitt W., and Hamilton-Miller J.M. Reassessment of the rationale for the combinations of sulphonamides with diaminopyrimidines. J Chemother 5 (1993) 465
3. American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Urinary Tract Infection. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 103 (1999) 843
4. Brackett C.C. Sulfonamide allergy and cross-reactivity. Curr Allergy Asthma Rep 7 (2007) 41
5. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113 suppl. (2002) 5S
6. Wikler M.A. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard. 10th ed. (2008), Clinical and Laboratory Standards Institute®, Wayne, Pennsylvania 72
7. Greenwood D., and O'Grady F. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. J Clin Pathol 29 (1976) 162
8. Lewis E.L., Anderson J.D., and Lacey R.W. A reappraisal of the antibacterial action of cotrimoxazole in vitro. J Clin Pathol 27 (1974) 87
9. Reeves D.S., and Wilkinson P.J. The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues. Infection 7 suppl. (1979) S330
10. Brumfitt W., Hamilton-Miller J.M., Havard C.W., et al. Trimethoprim alone compared to co-trimoxazole in lower respiratory infections: pharmacokinetics and clinical effectiveness. Scand J Infect Dis 17 (1985) 99
11. Anderson J.D., Lacey R.W., Lewis E.L., et al. Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection. J Clin Pathol 27 (1974) 619
12. Brumfitt W., and Pursell R. Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection. Br Med J 2 (1972) 673
13. Dibbern Jr. D.A., and Montanaro A. Allergies to sulfonamide antibiotics and sulfur-containing drugs. Ann Allergy Asthma Immunol 100 (2008) 91
14. Hoppu K., and Arjomaa P. Difference in trimethoprim pharmacokinetics between children and adults. Chemotherapy 30 (1984) 283
15. Ahmed M., Sloan J.E., and Clemente E. Clinical efficacy and safety of trimethoprim HC1 oral solution in the treatment of acute otitis media and urinary tract infection in children. Today's Therapeutic Trends 19 (2001) 198
16. Brogden R., Carmine A., Heel R., et al. Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections. Drugs 23 (1982) 405
17. Assaad D., From L., Ricciatti D., et al. Toxic epidermal necrolysis in Stevens-Johnson syndrome. Can Med Assoc J 118 (1978) 154
18. Gruchalla R.S. 10. Drug allergy. J Allergy Clin Immunol 111 (2003) S548
19. Patel R.M., and Marfatia Y.S. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 74 (2008) 430
20. Park J., Matsui D., and Rieder M.J. Multiple antibiotic sensitivity syndrome in children. Can J Clin Pharmacol 7 (2000) 38
21. Brumfitt W., and Hamilton-Miller J.M. Combinations of sulphonamides with diaminopyrimidines: how, when and why?. J Chemother 7 (1995) 136
22. Lonjou C., Borot N., Sekula P., et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18 (2008) 99
23. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 22 suppl. (2003) 49
24. Sahm D.F., Thornsberry C., Mayfield D.C., et al. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 45 (2001) 1402
25. Zhanel G.G., Hisanaga T.L., Laing N.M., et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 27 (2006) 468
26. Nicolle L.E. Resistant pathogens in urinary tract infections. J Am Geriatr Soc 50 (2002) S230
27. Cendron M. Antibiotic prophylaxis in the management of vesicoureteral reflux. Adv Urol (2008) 825475
28. Dhillon H.K. Prenatally diagnosed hydronephrosis: the Great Ormond Street experience. Br J Urol 81 suppl. (1998) 39
29. Hoppu K., Koskimies O., and Tuomisto J. Trimethoprim pharmacokinetics in children with renal insufficiency. Clin Pharmacol Ther 42 (1987) 181
30. Williams G.J., Wei L., Lee A., et al. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev 3 (2006) CD001534